Singapore markets closed

Akero Therapeutics, Inc. (AKRO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
20.08+0.19 (+0.96%)
At close: 04:00PM EDT
20.08 0.00 (0.00%)
After hours: 04:20PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
141,798
141,798
85,284
81,759
64,916
Selling general and administrative
31,072
31,072
29,872
19,127
15,238
Total operating expenses
172,870
172,870
115,156
100,886
80,154
Operating income or loss
-172,870
-172,870
-115,156
-100,886
-80,154
Interest expense
3,099
3,099
739
0
-
Total other income/expenses net
-
-
3,862
109
947
Income before tax
-151,759
-151,759
-112,033
-100,777
-79,207
Income from continuing operations
-151,759
-151,759
-112,033
-100,777
-79,207
Net income
-151,759
-151,759
-112,033
-100,777
-79,207
Net income available to common shareholders
-151,759
-151,759
-112,033
-100,777
-79,207
Basic EPS
-2.29
-2.89
-2.87
-2.89
-2.52
Diluted EPS
-2.29
-2.89
-2.87
-2.89
-2.52
Basic average shares
50,342
52,568
38,985
34,827
31,463
Diluted average shares
50,342
52,568
38,985
34,827
31,463